Our goal is to establish a global health ecosystem that effectively connects users with relevant segments of the healthcare industry, helping people to realize their health and wellness needs.
Our core business is selling smart wearables that help users become healthier. The company has developed a platform of proprietary technology which drives a broadening line of smart health products for consumers, and analytics services for population health.
Zepp Health launched it’s first smart wearable chip in 2018 and launched the third generation dual-core RISC-V AI Chip in 2021. The company is excited to have developed a wearable chip that provides an ideal balance between function, performance and power consumption.
This chip will continue to be a significant differentiator in performance that consumers will experience from the company's smart health products.
Zepp Health has established a complete ecosystem of sensors and AI-driven data engines, including: BioTracker™2, a second-generation PPG biology tracking optical sensor; RealBeats™2, a second-generation heart rate engine; OxygenBeats™, a blood oxygen engine; SomnusCare™, a sleep data engine; PumpBeats™, a non-invasive and sleeveless blood pressure measurement system; ExerSense™, an AI recognition engine for motion patterns based on sports big data, and Zepp Health-PAI™, a human health assessment system.
The Zepp OS is an extremely battery efficient smartwatch operating system that Zepp Health announced in July 2021. The company created the innovative Zepp OS architecture to enable “24/7 health monitoring” so users can benefit from the most comprehensive health insights to improve their health.
The Zepp OS Mini Program Framework, named Zeus, allows developers to easily create lean customized apps with enhanced value for smartwatch users.
Zepp Health is one of the largest global developers of smart wearable health and consumer fitness devices, shipping 46 million units in 2020 under its Zepp and Amazfit brands. In 2020, the company recognized that its engineering expertise in AI and miniaturization could be applied to emerging industrial medical technologies, and began developing partnerships with several disruptive medical imaging companies.